SEC Form 4 · accession 0001654954-19-000378
CorMedix Inc. · CRMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Janet Dillione
Director
Period of report
Jan 10, 2019
Accepted (ET)
Jan 11, 2019 · 4:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001410098
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1 | Jan 10, 2019 | A | 12,500 | — | A | 133,909 | D | |
| Restricted Stock UnitsF1 | Jan 10, 2019 | A | 5,000 | — | A | 138,909 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy Common Stock)F2 | $1.66 | Jan 10, 2019 | A | 75,000 | A | — | Jan 10, 2029 | Common Stock | 75,000 | 75,000 | D |
| Phantom StockF3 | — | holding | — | — | — | — | — | Common Stock | 6,637 | 6,637 | D |
| Phantom StockF3 | — | holding | — | — | — | — | — | Common Stock | 13,636 | 13,636 | D |
| Phantom StockF3 | — | holding | — | — | — | — | — | Common Stock | 37,500 | 37,500 | D |
| Stock Option (Right to Buy Common Stock)F4 | $0.57 | holding | — | — | — | — | Feb 16, 2028 | Common Stock | 40,000 | 40,000 | D |
| Phantom StockF3 | — | holding | — | — | — | — | — | Common Stock | 13,392 | 13,392 | D |
| Phantom StockF3 | — | holding | — | — | — | — | — | Common Stock | 15,625 | 15,625 | D |
| Phantom StockF3 | — | holding | — | — | — | — | — | Common Stock | 20,833 | 20,833 | D |
| Stock Option (Right to Buy Common Stock)F5 | $2.24 | holding | — | — | — | — | Feb 21, 2027 | Common Stock | 40,000 | 40,000 | D |
| Phantom StockF3 | — | holding | — | — | — | — | — | Common Stock | 3,472 | 3,472 | D |
| Phantom StockF3 | — | holding | — | — | — | — | — | Common Stock | 4,143 | 4,143 | D |
| Stock Option (Right to Buy Common Stock)F6 | $3.03 | holding | — | — | — | — | Aug 11, 2025 | Common Stock | 50,000 | 50,000 | D |
| Phantom StockF3 | — | holding | — | — | — | — | — | Common Stock | 1,415 | 1,415 | D |
| Stock Option (Right to Buy Common Stock)F7 | $3.03 | holding | — | — | — | — | Feb 21, 2026 | Common Stock | 95,000 | 95,000 | D |
| Phantom StockF3 | — | holding | — | — | — | — | — | Common Stock | 3,831 | 3,831 | D |
| Phantom StockF3 | — | holding | — | — | — | — | — | Common Stock | 2,767 | 2,767 | D |
| Phantom StockF3 | — | holding | — | — | — | — | — | Common Stock | 4,335 | 4,335 | D |
| Phantom StockF3 | — | holding | — | — | — | — | — | Common Stock | 15,306 | 15,306 | D |
Explanation of responses
- F1These shares consist of restricted stock units granted on 01/10/2019. These restricted stock units will vest monthly with full vesting on the first anniversary of the date of grant, subject to continued service on the board.
- F2These options were granted on 01/10/2019. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.
- F3Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.
- F4These options were granted on 2/16/2018. These options vest in full on the first anniversary of the date of grant, subject to continued service on the board.
- F5These options were granted on 2/21/2017. The options vest in full on the first anniversary of the date of grant, subject to continued service on the board.
- F6These options were granted on 8/12/2015. The options vest as follows: 1/3 on 8/12/2015, 1/3 on 8/12/2016, and 1/3 on 8/12/2017.
- F7These options were granted on 2/21/2016. These options vest in full on the first anniversary of the date of grant, subject to continued service on the board.